The institute,however, was yet to approach the pharma companies for its commercial manufacturing and sale in the market. Stating that her institute is also focussing on developing new drugs against tuberculosis and resistant TB strains,Kalia claimed NIPER-A had developed as many as eight molecules exhibiting potent activity against Rifampicin-resistant strain of tuberculosis.
The institute conducts MS (Pharma) and doctoral courses. So far, 84 students have passed out from the insti-tute and 92 are currently studying for different postgrad-uate courses. A total of 15 students have enrolled for PhD programmes. The institute, which is among seven national institutes set up in 2007 by the Centre, is currently operat-ing from MB Institute of Mental Health in Ahmedabad.
Pharm.D @ SRIPMS-CBE-TN